TIAA CREF INVESTMENT MANAGEMENT LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$3,109,000
+33.0%
32,544
-1.3%
0.00%0.0%
Q4 2018$2,337,000
-60.3%
32,988
-52.1%
0.00%0.0%
Q3 2018$5,888,000
+36.4%
68,908
+84.9%
0.00%
-33.3%
Q2 2018$4,318,000
+37.8%
37,260
-3.8%
0.00%
+50.0%
Q1 2018$3,133,000
+39.6%
38,717
+1.2%
0.00%
+100.0%
Q4 2017$2,244,000
+16.7%
38,241
-6.9%
0.00%0.0%
Q3 2017$1,923,000
+24.5%
41,084
-4.3%
0.00%0.0%
Q2 2017$1,545,000
+15.7%
42,951
-0.9%
0.00%0.0%
Q1 2017$1,335,000
-16.2%
43,333
-8.9%
0.00%0.0%
Q4 2016$1,594,000
-5.4%
47,591
-24.8%
0.00%0.0%
Q3 2016$1,685,000
-14.7%
63,315
-29.4%
0.00%
-50.0%
Q2 2016$1,976,000
-24.3%
89,624
+0.9%
0.00%0.0%
Q1 2016$2,609,000
+36.2%
88,848
+53.2%
0.00%
+100.0%
Q4 2015$1,915,000
-21.6%
58,008
-14.2%
0.00%
-50.0%
Q3 2015$2,443,000
-21.3%
67,597
-2.0%
0.00%0.0%
Q2 2015$3,104,000
+74.5%
68,996
+18.8%
0.00%
+100.0%
Q1 2015$1,779,000
-40.6%
58,091
-1.3%
0.00%
-50.0%
Q4 2014$2,994,000
+26.3%
58,879
-1.7%
0.00%0.0%
Q3 2014$2,370,000
-26.4%
59,885
-19.9%
0.00%0.0%
Q2 2014$3,220,000
+11.0%
74,762
+3.1%
0.00%0.0%
Q1 2014$2,901,000
+199.1%
72,546
+104.0%
0.00%
+100.0%
Q4 2013$970,000
+185.3%
35,570
+140.1%
0.00%
Q3 2013$340,000
+33.9%
14,815
+3.2%
0.00%
Q2 2013$254,00014,3520.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders